GE Flyrcado was a new radiotracer for cardiac MPI that had too many benefits to communicate, and the industry’s biggest launch event was only six weeks away.
Most radiotracers focus on their technical performance or operational benefits in an effort to compete, overlooking their benefit to society. Flyrcado had the opportunity to not just be a better radiotracer, but to fundamentally change Cardiac PET.
By positioning Flyrcado as the innovation that would finally bring cardiac PET to more people and aligning that message with KOLs, booth, and materials at launch, GE Healthcare had a booth so packed at ACC that trade show officials attempted to clear the aisles.